Medicine & Life Sciences

1. Atrial Fibrillation 100%
2. Nova Scotia 77%
3. Canada 62%
4. Myocardial Infarction 55%
5. Acute Coronary Syndrome 36%
6. Heart Failure 36%
7. Stroke 35%
8. Guidelines 29%
9. Mortality 28%
10. Anticoagulants 27%
11. Atrial Flutter 26%
12. Population 24%
13. Primary Health Care 24%
14. Physicians 23%
15. Delivery of Health Care 22%
16. Warfarin 21%
17. Health 20%
18. Family Physicians 20%
19. Cardiovascular Diseases 20%
20. Hospitalization 19%
21. Therapeutics 18%
22. Risk Management 18%
23. Ontario 17%
24. Patient Care 14%
25. Cohort Studies 14%
26. Angiotensin-Converting Enzyme Inhibitors 13%
27. Hemorrhage 13%
28. Clinical Decision Support Systems 13%
29. Percutaneous Coronary Intervention 13%
30. Thrombolytic Therapy 13%
31. Disease Management 12%
32. Costs and Cost Analysis 12%
33. Registries 12%
34. Confidence Intervals 11%
35. Secondary Prevention 11%
36. Coronary Artery Bypass 11%
37. Myocardial Ischemia 11%
38. Quality of Health Care 10%
39. Pragmatic Clinical Trials 10%
40. Prescriptions 10%
41. Practice Guidelines 10%
42. Implantable Defibrillators 10%
43. Hydroxymethylglutaryl-CoA Reductase Inhibitors 10%
44. Evidence-Based Medicine 9%
45. Primary Prevention 9%
46. Health Expenditures 9%
47. Decision Support Techniques 8%
48. Cardiologists 8%
49. ST Elevation Myocardial Infarction 8%
50. Outpatients 8%